Damage to neurons of the cerebral cortex in acute poisoning with baclofen and its combination with ethanol

Abstract

BACKGROUND: The number of poisoning with a muscle relaxant baclofen has increased recently. The brain is one of the target organs in baclofen poisoning.

AIM: To identify and quantify cerebral cortex neuron damage in baclofen and baclofen ethanol poisoning.

MATERIAL AND METHODS: A histological study of rat cerebral cortex was performed. The controls (n = 5) received neither baclofen nor ethanol. Groups 1 and 3 received baclofen (85 mg/kg), whereas groups 2 and 4 received baclofen (85 mg/kg) and ethanol (7 ml/kg). Groups 1 and 3 were euthanized 4 h after the drug administration, whereas groups 2 and 4 were euthanized after 24 h. Histological sections were stained with hematoxylin and eosin and by the Nissl method and examined by light microscopy (×400). The number of damaged neurons was calculated. Statistical processing was performed by the nonparametric Mann–Whitney method.

RESULTS: Neurons with reversible and irreversible changes in the controls accounted for 13% and 9%, respectively. At 4 h after baclofen administration, neurons with reversible and irreversible changes accounted for 22% and 21%; 4 h after baclofen and ethanol administration, 24% and 29%; 24 h after baclofen administration, 25% and 37%, respectively. Baclofen and ethanol administration caused an increase in the share of neurons with reversible (27%) and irreversible (41%) changes. The differences between group 3 and the control group were significant, and the difference was significant when group 4 was compared with the control group and group 3.

CONCLUSION: Understanding the processes in the brain during baclofen and baclofen ethanol administration will allow the provision of medical care to this category of patients more effectively. The signs of brain neuron damage, along with the results of forensic chemical analysis, can be used to establish the immediate cause of death.

Keywords

poisoning / baclofen / ethanol / damage to neurons of the cerebral cortex reversible and irreversible

References

[1] Livanov GA, Lodyagin AN, Razina AА, et al. Favorable outcome of severe acute Methadone poisoning (clinical case). General Reanimatology. 2018;14(5):25–31. (In Russ). doi: 10.15360/1813-9779-2018-5-25-31

[2] Ливанов Г.А., Лодягин А.Н., Разина А.А., и др. Благоприятный исход острого тяжелого отравления метадоном (клиническое наблюдение) //Общая реаниматология. 2018. Т. 14, № 5. С. 25–31. doi: 10.15360/1813-9779-2018-5-25-31

[3] Romanova OL, Sudukov DV, Golubev MA, et al. Pathologic changes in the liver during acute exposure to clozapine and its combination with ethanol (experimental study). General Reanimatology. 2019;15(2):27–35. (In Russ). doi: 10.15360/1813-9779-2019-2-27-35

[4] Романова О.Л., Сундуков Д.В., Голубев М.А., и др. Патологические изменения в печени при острых отравлениях клозапином и его сочетанием с этанолом (экспериментальное исследование) //Общая реаниматология. 2019. Т. 15, № 2. С. 27–35. doi: 10.15360/1813-9779-2019-2-27-35

[5] Kuznetsov BV, Lodyagin AN, Batotsyrenov BV, et al. Features of clinical manifestation of acute methadone poisoning complicated by development of positional compression syndrome and systemic rhabdomyolysis. Toxicological Bulletin. 2015;(4):38–43. (In Russ).

[6] Кузнецов Б.В., Лодягин А.Н., Батоцыренов Б.В., и др. Особенности клинического течения острых отравлений метадоном, осложненных развитием синдрома позиционного сдавления и системного рабдомиолиза // Токсикологический вестник. 2015. № 4. С. 38–43.

[7] Mashkovsky MD. Medicinal products: Manual for doctors. 17th ed. Moscow: Novaya volna; 2019. Р. 73–74. (In Russ).

[8] Машковский М.Д. Лекарственные средства: пособие для врачей. 17-е изд. Москва: Новая волна, 2019. С. 73–74.

[9] Product Information Clofen. TGA eBusiness Services. Millers Point, Australia: Alphapharm Pty Limited. 7 June 2017. Retrieved 15 August 2017.

[10] Baclofen Monograph for Professionals. Drugs.com. American Society of Health-System Pharmacists. Retrieved 3 March 2019.

[11] Issa SY, Hafez EM, El-Banna AS, et al. Baclofen systemic toxicity: experimental histopathological and biochemical study. Hum Exp Toxicol. 2018;37(4):431–441. doi: 10.1177/0960327117712369

[12] Issa S.Y., Hafez E.M., El-Banna A.S., et al. Baclofen systemic toxicity: experimental histopathological and biochemical study // Hum Exp Toxicol. 2018. Vol. 37, N 4. Р. 431–441. doi: 10.1177/0960327117712369

[13] Kampman KM. New medications for the treatment of cocaine dependence. Psychiatry (Edgmont). 2005;2(12):44–48.

[14] Kampman K.M. New medications for the treatment of cocaine dependence //Psychiatry (Edgmont). 2005. Vol. 2, N 12. Р. 44–48.

[15] Froestl W. Chemistry and pharmacology of GABAB receptor ligands. Adv Pharmacology. 2010;58:19–62. doi: 10.1016/S1054-3589(10)58002-5

[16] Froestl W. Chemistry and pharmacology of GABAB receptor ligands // Adv Pharmacol. 2010. Vol. 58. Р. 19–62. doi: 10.1016/S1054-3589(10)58002-5

[17] Yogeeswari P, Ragavendran JV, Sriram D. An update on GABA analogs for CNS drug discovery. Recent Pat CNS Drug Discov. 2006;1(1):113–118. doi: 10.2174/157488906775245291

[18] Yogeeswari P., Ragavendran J.V., Sriram D. An update on GABA analogs for CNS drug discovery // Recent Pat CNS Drug Discov. 2006. Vol. 1, N 1. Р. 113–118. doi: 10.2174/157488906775245291

[19] Mezler M, Müller T, Raming K. Cloning and functional expression of GABA(B) receptors from Drosophila. Eur J Neurosci. 2001;13(3):477–486. doi: 10.1046/j.1460-9568.2001.01410.x

[20] Mezler M., Müller T., Raming K. Cloning and functional expression of GABA(B) receptors from Drosophila //Eur J Neurosci. 2001. Vol. 13, N 3. Р. 477–486. doi: 10.1046/j.1460-9568.2001.01410.x

[21] Van den Brink W. Baclofen: a game changer in the treatment of alcohol dependence. Alcohol Alcohol. 2020;55(1):46–47. doi: 10.1093/alcalc/agz085

[22] Van den Brink W. Baclofen: a game changer in the treatment of alcohol dependence // Alcohol Alcohol. 2020. Vol. 55, N 1. Р. 46–47. doi: 10.1093/alcalc/agz085

[23] Krupickij EM, Rybakova KV, Kiselev AS, et al. Efficacy and safety of baclofen in the treatment of alcohol dependence (double-blind randomized placebo-controlled pilot study). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;115(6):53–62. (In Russ). doi: 10.17116/jnevro20151156153-62

[24] Крупицкий Е.М., Рыбакова К.В., Киселев А.С., и др. Эффективность и безопасность применения баклофена в терапии алкогольной зависимости (двойное слепое рандомизированное плацебоконтролируемое пилотное исследование) // Журнал неврологии и психиатрии им. С.С. Корсакова. 2015. Т. 115, № 6. С. 53–62. doi: 10.17116/jnevro20151156153-62

[25] Schiess MC, Eldabe S, Konrad P, et al. Intrathecal baclofen for severe spasticity: longitudinal data from the product surveillance registry. Neuromodulation. 2020;23(7):996–1002. doi: 10.1111/ner.13097

[26] Schiess M.C., Eldabe S., Konrad P., et al. Intrathecal baclofen for severe spasticity: longitudinal data from the product surveillance registry // Neuromodulation. 2020. Vol. 23, N 7. Р. 996–1002. doi: 10.1111/ner.13097

[27] McLaughlin MJ, He Y, Brunstrom-Hernandez J, et al. Response in children with cerebral palsy. PM R. 2018;10(3):235–243. doi: 10.1016/j.pmrj.2017.08.441

[28] McLaughlin M.J., He Y., Brunstrom-Hernandez J., et al. Response in children with cerebral palsy // PM R. 2018. Vol. 10, N 3. Р. 235–243. doi: 10.1016/j.pmrj.2017.08.441

[29] Navarrete-Opazo AA, Gonzalez W, Nahuelhual P. Effectiveness of oral baclofen in the treatment of spasticity in children and adolescents with cerebral palsy. Arch Phys Med Rehabil. 2016;97(4):604–618. doi: 10.1016/j.apmr.2015.08.417

[30] Navarrete-Opazo A.A., Gonzalez W., Nahuelhual P. Effectiveness of oral baclofen in the treatment of spasticity in children and adolescents with cerebral palsy // Arch Phys Med Rehabil. 2016. Vol. 97, N 4. Р. 604–618. doi: 10.1016/j.apmr.2015.08.417

[31] Furr-Stimming E, Boyle AM, Schiess MC. Spasticity and Intrathecal Baclofen. Semin Neurol. 2014;34(5):591–596. doi: 10.1055/s-0034-1396012

[32] Furr-Stimming E., Boyle A.M., Schiess M.C. Spasticity and intrathecal Baclofen // Semin Neurol. 2014. Vol. 34, N 5. Р. 591–596. doi: 10.1055/s-0034-1396012

[33] Ostermann ME, Young B, Sibbald WJ, Nicole MW. Coma mimicking brain death following baclofen overdose. Intensive Care Med. 2000;26(8):1144–1146. doi: 10.1007/s001340051330

[34] Ostermann M.E., Young B., Sibbald W.J., Nicole M.W. Coma mimicking brain death following baclofen overdose // Intensive Care Med. 2000. Vol. 26, N 8. Р. 1144–1146. doi: 10.1007/s001340051330

[35] Motta F, Antonello CE. Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience. J Neurosurg Pediatr. 2014;13(3):301–306. doi: 10.3171/2013.11.PEDS13253

[36] Motta F., Antonello C.E. Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience // J Neurosurg Pediatr. 2014. Vol. 13, N 3. Р. 301–306. doi: 10.3171/2013.11.PEDS13253

[37] Defayette A, Perrello A, Brewer T, et al. Enteral baclofen withdrawal managed with intravenous dexmedetomidine: a case report. Am J Health Syst Pharm. 2020;77(5):352–355. doi: 10.1093/ajhp/zxz332

[38] Defayette A., Perrello A., Brewer T., et al. Enteral baclofen withdrawal managed with intravenous dexmedetomidine: a case report // Am J Health Syst Pharm. 2020. Vol. 77, N 5. Р. 352–355. doi: 10.1093/ajhp/zxz332

[39] Reynolds K, Kaufman R, Korenoski A, et al. Trends in gabapentin and baclofen exposures reported to U.S. poison centers. Clin Toxicol. 2019;58(7):763–772. doi: 10.1080/15563650.2019.1687902

[40] Reynolds K., Kaufman R., Korenoski A., et al. Trends in gabapentin and baclofen exposures reported to U.S. poison centers // Clin Toxicol. 2019. Vol. 58, N 7. Р. 763–772. doi: 10.1080/15563650.2019.1687902

[41] Charifou Y, Martinet O, Jabot J, et al. Baclofen intoxication cases in an intensive care unit. Anaesth Crit Care Pain Med. 2016;35(2):169–170. doi: 10.1016/j.accpm.2015.10.003

[42] Charifou Y., Martinet O., Jabot J., et al. Baclofen intoxication cases in an intensive care unit // Anaesth Crit Care Pain Med. 2016. Vol. 35, N 2. Р. 169–170. doi: 10.1016/j.accpm.2015.10.003

[43] Dukova OA, Pokrovskij AA, Melent’ev AB, et al. Lethal intoxication with baclofen. Sudebno-meditsinskaya ekspertiza. 2015;58(1):35–39. (In Russ). doi: 10.17116/sudmed201558135-39

[44] Дукова О.А., Покровский А.А., Мелентьев А.Б., и др. Смертельное отравление баклофеном // Судебно-медицинская экспертиза. 2015. Т. 58, № 1. С. 35–39. doi: 10.17116/sudmed201558135-39

[45] Smith R, Havens J, Walsh S. Gabapentin misuse, abuse and diversion: a systematic review. Addiction. 2016;111(7):1160–1174. doi: 10.1111/add.13324

[46] Smith R., Havens J., Walsh S. Gabapentin misuse, abuse and diversion: a systematic review // Addiction. 2016. Vol. 111, N 7. Р. 1160–1174. doi: 10.1111/add.13324

[47] Tagirov AA, Larionov SS. Acute intentional poisoning with the drug Baclofen in adolescents. Uspekhi sovremennogo estestvoznaniya.2014;(6):94–94. (In Russ).

[48] Тагиров А.А., Ларионов С.С. Острые преднамеренные отравления медикаментозным препаратом «баклофен» у подростков // Успехи современного естествознания. 2014. № 6. С. 94.

[49] De Marcellus C, le Bot S, Decleves X, et al. Report of severe accidental baclofen intoxication in a healthy 4-year-old boy and review of the literature. Arch Pediatr. 2019;26(8):475–478. doi: 10.1016/j.arcped.2019.10.003

[50] De Marcellus C., le Bot S., Decleves X., et al. Report of severe accidental baclofen intoxication in a healthy 4-year-old boy and review of the literature // Arch Pediatr. 2019. Vol. 26, N 8. Р. 475–478. doi: 10.1016/j.arcped.2019.10.003

[51] Weißhaar GF, Hoemberg M, Bender K, et al. Baclofen intoxication: a “fun drug” causing deep coma and nonconvulsive status epilepticus--a case report and review of the literature. Eur J Pediatr. 2012;171(10):1541–1547. doi: 10.1007/s00431-012-1780-y

[52] Weißhaar G.F., Hoemberg M., Bender K., et al. Baclofen intoxication: a “fun drug” causing deep coma and nonconvulsive status epilepticus--a case report and review of the literature // Eur J Pediatr. 2012. Vol. 171, N 10. Р. 1541–1547. doi: 10.1007/s00431-012-1780-y

[53] Ostermann ME, Young B, Sibbald WJ, Nicole MW. Coma mimicking brain death following baclofen overdose. Intensive Care Med. 2000;26(8):1144–1146. doi: 10.1007/s001340051330

[54] Ostermann M.E., Young B., Sibbald W.J., Nicole M.W. Coma mimicking brain death following baclofen overdose // Intensive Care Med. 2000. Vol. 26, N 8. Р. 1144–1146. doi: 10.1007/s001340051330

[55] Roberge RJ, Martin TG, Hodgman M, et al. Supraventricular tachyarrhythmia associated with baclofen overdose. Clin Toxil. 1994;32(3):291–297. doi: 10.3109/15563659409017961

[56] Roberge R.J., Martin T.G., Hodgman M., et al. Supraventricular tachyarrhythmia associated with baclofen overdose // Clin Toxil. 1994. Vol. 32, N 3. Р. 291–297. doi: 10.3109/15563659409017961

[57] Katyal R, Samkutty D, Muzammil SM, Saucedo S. Baclofen toxicity presenting as myoclonic status epilepticus. Neurol Clin Pract. 2019;9(6):516–518. doi: 10.1212/CPJ.0000000000000686

[58] Katyal R., Samkutty D., Muzammil S.M., Saucedo S. Baclofen toxicity presenting as myoclonic status epilepticus // Neurol Clin Pract. 2019. Vol. 9, N 6. Р. 516–518. doi: 10.1212/CPJ.0000000000000686

[59] Rolland B., Deheul S., Danel T., et al. A case of de novo seizures following a probable interaction of high-dose baclofen with alcohol. Alcohol Alcohol. 2012;47(5):577–580. doi: 10.1093/alcalc/ags076

[60] Rolland B., Deheul S., Danel T., et al. A case of de novo seizures following a probable interaction of high-dose baclofen with alcohol // Alcohol Alcohol. 2012. Vol. 47, N 5. Р. 577–580. doi: 10.1093/alcalc/ags076

[61] De Witte LD, Dekker D, Veraart J, et al. [Aggression and restlessness following baclofen overdose: the narrow line between intoxication and withdrawal symptoms]. Ned Tijdschr Geneeskd. 2016;160:A9604. (In Dutch).

[62] De Witte L.D., Dekker D., Veraart J., et al. [Aggression and restlessness following baclofen overdose: the narrow line between intoxication and withdrawal symptoms] // Ned Tijdschr Geneeskd. 2016. Vol. 160. Р. A9604. (In Dutch).

[63] Wolf ME, Mosnaim AD. Baclofen-induced manic symptoms: case report and systematic review. Psychosomatics. 2017;58(1):94. doi: 10.1016/j.psym.2016.08.004

[64] Wolf M.E., Mosnaim A.D. Baclofen-induced manic symptoms: case report and systematic review // Psychosomatics. 2017. Vol. 58, N 1. Р. 94. doi: 10.1016/j.psym.2016.08.004

[65] Chartier M, Tannous S, Benturquia N, et al. Baclofen-induced neuro-respiratory toxicity in the rat: contribution of tolerance and characterization of withdrawal syndrome. Toxicol Sci. 2018;164(1):153–165. doi: 10.1093/toxsci/kfy073

[66] Chartier M., Tannous S., Benturquia N., et al. Baclofen-induced neuro-respiratory toxicity in the rat: contribution of tolerance and characterization of withdrawal syndrome // Toxicol Sci. 2018. Vol. 164, N 1. Р. 153–165. doi: 10.1093/toxsci/kfy073

[67] Chartier M, Malissin I, Tannous S, et al. Baclofen-induced encephalopathy in overdose ― Modeling of the electroencephalographic effect/concentration relationships and contribution of tolerance in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 2018;86(30):131–139. doi: 10 .1016/j.pnpbp.2018.05.016

[68] Chartier M., Malissin I., Tannous S., et al. Baclofen-induced encephalopathy in overdose ― Modeling of the electroencephalographic effect/concentration relationships and contribution of tolerance in the rat // Prog Neuropsychopharmacol Biol Psychiatry. 2018. Vol. 86, N 30. Р. 131–139. doi: 10 .1016/j.pnpbp.2018.05.016

[69] Mikhaylov AY, Berezina IY, Potskhveriya MM, Sumsky LI. Electroencephalography showing dying brain in a patient with acute baclofen poisoning. Neotlozhnaya medicinskaya pomoshch’. Zhurnal im. N.V. Sklifosovskogo. 2017;6(4):371–375. (In Russ). doi: 10.23934/2223-9022-2017-6-4-371-375

[70] Михайлов А.Ю., Березина И.Ю., Поцхверия М.М., Сумский Л.И. Электроэнцефалограмма, имитирующая умирание головного мозга, при остром отравлении баклофеном // Неотложная медицинская помощь. Журнал им. Н.В. Склифосовского. 2017. Т. 6, № 4. С. 371–375. doi: 10.23934/2223-9022-2017-6-4-371-375

[71] Bashirova AR, Sundukov DV, Babkina AS, et al. Morphometry of cortical neurons in acute clozapine and ethanol poisoning. General Reanimatology. 2020;16(6):19–30. (In Russ). doi: 10.15360/1813-9779-2020-6-19-30

[72] Баширова А.Р., Сундуков Д.В., Бабкина А.С., и др. Морфометрические изменения клеток коры головного мозга при острых отравлениях клозапином в сочетании с этиловым спиртом // Общая реаниматология. 2020. Т. 16, № 6. С. 19–30. doi: 10.15360/1813-9779-2020-6-19-30

[73] Chapman RW, Hey JA, Rizzo CA, Bolser DC. GABAB receptors in the lung. Trends Pharmacol Sci. 1993;14(1):26–29. doi: 10.1016/0165-6147(93)90110-6

[74] Chapman R.W., Hey J.A., Rizzo C.A., Bolser D.C. GABAB receptors in the lung // Trends Pharmacol Sci. 1993. Vol. 14, N 1. Р. 26–29. doi: 10.1016/0165-6147(93)90110-6

[75] Mizuta K, Xu D, Pan Y, et al. GABAA receptors are expressed and facilitate relaxation in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2008;294(6):L1206–1216. doi: 10.1152/ajplung.00287.2007

[76] Mizuta K., Xu D., Pan Y., et al. GABAA receptors are expressed and facilitate relaxation in airway smooth muscle // Am J Physiol Lung Cell Mol Physiol. 2008. Vol. 294, N 6. Р. L1206–1216. doi: 10.1152/ajplung.00287.2007

RIGHTS & PERMISSIONS

Eco-Vector